Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized comparison of transdermal Testim versus intramuscular testosterone enanthate in male hypogonadism/delayed puberty
2006-005200-13Phase 2Terminated
- Sponsor
- Ipsen
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of testosterone in Hypoandrogenism (TD) and delayed puberty (2 arms), sponsored by Ipsen. Primary endpoint: Adequate pubertal development at week 96. Started May 2007; status: terminated.
02
Drugs
testosterone
03
Conditions
Hypoandrogenism (TD)delayed puberty
Beyond the preview
Go deeper on 2006-005200-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005200-13.